Ecromeximab

• Description:

  Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells[1].

• Product Name Alternative:

  KM 871; KW 2871

• UNSPSC:

  12352203

• Target:

  Others

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Others

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/ecromeximab.html

• Purity:

  99.70

• Solubility:

  10 mM in DMSO

• Smiles:

  [Ecromeximab]

• Molecular Weight:

  (145.26 kDa)

• References & Citations:

  [1]Ecromeximab. IMGT.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  Store at -80°C for 2 years

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  No Development Reported

• CAS Number:

  [292819-64-8]